Radiomics model based on preoperative 18F-fluorodeoxyglucose PET predicts N2-3b lymph node metastasis in gastric cancer patients

MLA

Xiu-Qing, Xue, et al. “Radiomics Model Based on Preoperative 18F-Fluorodeoxyglucose PET Predicts N2-3b Lymph Node Metastasis in Gastric Cancer Patients.” Nuclear Medicine Communications, vol. 43, Dec. 2021, pp. 340–49. EBSCOhost, https://doi.org/10.1097/mnm.0000000000001523.

APA

Xiu-Qing, X., Wen-Ji, Y., Xiao-Liang, S., Xiao-Feng, L., Rong, N., Fei-Fei, Z., Yun-Mei, S., & Yue-Tao, W. (2021). Radiomics model based on preoperative 18F-fluorodeoxyglucose PET predicts N2-3b lymph node metastasis in gastric cancer patients. Nuclear Medicine Communications, 43, 340–349. https://doi.org/10.1097/mnm.0000000000001523

Chicago

Xiu-Qing, Xue, Yu Wen-Ji, Shao Xiao-Liang, Li Xiao-Feng, Niu Rong, Zhang Fei-Fei, Shi Yun-Mei, and Wang Yue-Tao. 2021. “Radiomics Model Based on Preoperative 18F-Fluorodeoxyglucose PET Predicts N2-3b Lymph Node Metastasis in Gastric Cancer Patients.” Nuclear Medicine Communications 43 (December): 340–49. doi:10.1097/mnm.0000000000001523.